BACE-1 inhibitors part 2: Identification of hydroxy ethylamines (HEAs) with reduced peptidic character
Brian Clarke(GlaxoSmithKline (United Kingdom)), Gareth Wayne(GlaxoSmithKline (United Kingdom)), Julie A. Hawkins(Charles River Laboratories (United Kingdom)), J. Mosley(GlaxoSmithKline (United Kingdom)), Sharon Sweitzer(GlaxoSmithKline (United States)), David Riddell(Eli Lilly (United States)), John M. Ward(University College London), Sally Redshaw(GlaxoSmithKline (United Kingdom)), Steven J. Stanway(GlaxoSmithKline (United Kingdom)), V. Soleil(GlaxoSmithKline (United Kingdom)), Ishrut Hussain(GlaxoSmithKline (United Kingdom)), David T. MacPherson(GlaxoSmithKline (United Kingdom)), Pam Theobald(GlaxoSmithKline (United Kingdom)), Emmanuel H. Demont(Age UK), G. Maile(GlaxoSmithKline (United Kingdom)), Peter H. Milner(GlaxoSmithKline (United Kingdom)), Alan Naylor(GlaxoSmithKline (United Kingdom)), D. Vesey(GlaxoSmithKline (United Kingdom)), R. Dunsdon(GlaxoSmithKline (United Kingdom)), Alistair O’Brien(GlaxoSmithKline (United Kingdom)), Paul Rowland(GlaxoSmithKline (United Kingdom)), Daryl S. Walter(GlaxoSmithKline (United Kingdom)), Geoffrey Stemp(GlaxoSmithKline (United Kingdom)), Colin Dingwall(GlaxoSmithKline (United Kingdom)), Andrew Faller(GlaxoSmithKline (United Kingdom)), Kathrine J. Smith(GlaxoSmithKline (United Kingdom)), Rosalie Matico(GlaxoSmithKline (United States))
Cited by 57
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
SUT2, a Putative Sucrose Sensor in Sieve Elements
|The Plant Cell|2000|354
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302